Major Depressive Disorder Patients Emphasize Long-Term Nature Of Disease In Feedback Meeting
Executive Summary
Externally hosted patient focused drug development meeting in MDD brings timely messages to US FDA during period of active regulatory review of new applications. Patients stress need for fewer side effects to encourage long-term medication use, and also want fast-acting meds that can “jump start” lifestyle changes.